Medi-Cal pharmacy clawback suspension to remain in place indefinitely

This Weekly’s Hot Topics

  • TONIGHT, Dr. Ashkan Lashkari to lead discussion on NSCLC/Metastatic NSCLC 
  • California Medical Malpractice Rates under attack by trial lawywers!  
  • Applications now being accepted for ANCO’s Travel Awards to Fellows and Young Clinicians  
  • Medi-Cal pharmacy clawback suspension to remain in place indefinitely.  

 

The trial lawyers are collecting signatures to place another anti-MICRA initiative on the November 2020 ballot. PROTECT MEDICAL MALPRACTICE RATES! California has THE LOWEST Medical Malpractice Rates due to MICRA. CAPP is reaching out to ALL affected parties to join the campaign to formally oppose the anti-MICRA ballot initiative. Being a member of CAPP does not automatically list you as a ballot initiative opponent. To read more click here and go to California News.

MOASC and ANCO have signed onto a letter, and encourages members to support, HR913, the Clinical Treatment Act. The bill would require Medicaid to cover routine care costs for patients on clinical trials with life-threatening conditions. To read more click here and go to National News.

CMS Administrator Seema Verma said the agency will introduce changes to prior authorization this year as part of efforts to improve health innovation and reduce administrative burdens, but she did not provide specifics. To read more click here and go to CMS News.

To view the complete California Oncology Weekly Newsletter, click on the date below.

February 18, 2020



No comments have been posted yet.